"With the rising prevalence of cancers and metabolic disorders, coupled with increasing investments in novel drug research and development, the demand for peptide therapeutics is surging. However, the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a leading biotech company specializing in the synthesis of complex peptides, announced today the appointment of Dr. Brad Pentelute as its new CEO ...

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amide Technologies, a leading biotech company specializing in the synthesis of complex peptides, announced today the appointment of Dr. Brad Pentelute as its new CEO.

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...